Rules for Pick of The Year (PoTY) 2023

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • antioch6
    replied
    Can you put my dad in with a cash position and change my pick to HYFM short please. I gave up on the nasdaq rally, so my guess is we head back to the lows and maybe panic from there. My dad is in cash and doesn't want to pick anything. He got angry when I asked him. Is there any way to include him in the contest with his choice?

    Leave a comment:


  • minni17
    replied
    KLIC going long

    Leave a comment:


  • BlueWolf
    replied
    My pick this year is going to be HUBS.

    Leave a comment:


  • BlueWolf
    replied
    Originally posted by antioch6 View Post
    Can you change my pick to GRBK long? please!
    Done. You now have GRBK.

    Leave a comment:


  • antioch6
    replied
    Can you change my pick to GRBK long? please!

    Leave a comment:


  • JohnHenry
    replied
    Originally posted by BlueWolf View Post
    Make sure you state whether you want to be long or short. I’ll assume long for CMC and RAVE.

    Leave a comment:


  • JohnHenry
    replied
    Nice! We have five players ready with picks. Two weeks left to get your picks in for the contest.

    Leave a comment:


  • rickflyboy
    replied
    ZIM all the way

    Leave a comment:


  • jiesen
    replied
    oh, yeah, and ALWAYS LONG!

    Leave a comment:


  • jiesen
    replied
    Gimme an O!
    Gimme an M!
    Gimme an E!
    Gimme an G!
    Gimme an A!

    What's that spell? OMGA!

    That's right, I do know how to spell, and I want to go long on Omega Therapeutics this year. Here's the scoop on OMGA:

    Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, as well as the mechanism that controls gene expression and aspect of an organism's life. The company's platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a range without altering native nucleic acid sequences. Its modular and programmable mRNA medicines, and Omega Epigenomic Controllers are designed to target specific epigenomic loci within insulated genomic domains from genome-wide DNA-sequences with single or multiple genes to treat and cure diseases through Precision Genomic Control. The company is advancing a pipeline of development candidates covering a range of disease areas, including oncology, regenerative medicine, multigenic diseases, and select monogenic diseases. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

    Leave a comment:


  • Louetta
    replied
    Originally posted by mrmarket View Post
    always long!
    Gosh......

    Leave a comment:


  • mrmarket
    replied
    always long!

    Leave a comment:


  • BlueWolf
    replied
    Make sure you state whether you want to be long or short. I’ll assume long for CMC and RAVE.

    Leave a comment:


  • antioch6
    replied
    I'll go with CMC. It's the top stock on my screen, and if there is any truth to those commodity supercycles, it should do very well over the next few years.

    Leave a comment:


  • mrmarket
    replied
    put me down for RAVE...thanks Bluewolf and JohnHenry for running such a fun contest.

    Leave a comment:

Working...
X